Arish N. Shah

Arish N. Shah

Auto-generated profile, based on publicly available information

Arish N. Shah

Department of Biology, Massachusetts Institute of Technology

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 October 2020 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
ATAlison Taylor
Alison Taylor
EMElizabeth R. Macari
Elizabeth R. Macari
ICIris T. Chan
Iris T. Chan
MBMegan C. Blair
Megan C. Blair
SDSergei Doulatov
Sergei Doulatov
LZLeonard I. Zon
Leonard I. Zon
Diamond-Blackfan anemia (DBA) is a rare hematopoietic disease characterized by a block in red cell differentiation. Most DBA cases are caused by mutations in ribosomal proteins and characterized by higher than normal activity of the tumor suppressor p53. Higher p53 activity is thought to contribute to DBA phenotypes by inducing apoptosis during red blood cell differentiation. Currently, there are few therapies available for patients with DBA. We performed a chemical screen using zebrafish ribosomal small subunit protein 29 (rps29) mutant embryos that have a p53-dependent anemia and identified calmodulin inhibitors that rescued the phenotype. Our studies demonstrated that calmodulin inhibitors attenuated p53 protein amount and activity. Treatment with calmodulin inhibitors led to decreased p53 translation and accumulation but does not affect p53 stability. A U.S. Food and Drug Administration–approved calmodulin inhibitor, trifluoperazine, rescued hematopoietic phenotypes of DBA models in vivo in zebrafish and mouse models. In addition, trifluoperazine rescued these phenotypes in human CD34+ hematopoietic stem and progenitor cells. Erythroid differentiation was also improved in CD34+ cells isolated from a patient with DBA. This work uncovers a potential avenue of therapeutic development for patients with DBA.

3 September 2020 in JCI Insight
Verified
Journal Article
Open access
PDF file
UCUsua Oyarbide Cuervas-Mons
Usua Oyarbide Cuervas-Mons
ASArish N. Shah
Arish N. Shah
WAWilmer Amaya-Mejia
Wilmer Amaya-Mejia
MSMatthew Snyderman
Matthew Snyderman
MKMargaret J. Kell
Margaret J. Kell
SCSeth J. Corey
Seth J. Corey
Shwachman-Diamond syndrome (SDS) is characterized by exocrine pancreatic insufficiency, neutropenia, and skeletal abnormalities. Biallelic mutations in SBDS , which encodes a ribosome maturation factor, are found in 90% of SDS cases. Sbds –/– mice are embryonic lethal. Using CRISPR/Cas9 editing, we created sbds- deficient zebrafish strains. Sbds protein levels progressively decreased and became undetectable at 10 days postfertilization (dpf). Polysome analysis revealed decreased 80S ribosomes. Homozygous mutant fish developed normally until 15 dpf. Mutant fish subsequently had stunted growth and showed signs of atrophy in pancreas, liver, and intestine. In addition, neutropenia occurred by 5 dpf. Upregulation of tp53 mRNA did not occur until 10 dpf, and inhibition of proliferation correlated with death by 21 dpf. Transcriptome analysis showed tp53 activation through upregulation of genes involved in cell cycle arrest, cdkn1a and ccng1 , and apoptosis, puma and mdm2 . However, elimination of Tp53 function did not prevent lethality. Because of growth retardation and atrophy of intestinal epithelia, we studied the effects of starvation on WT fish. Starved WT fish showed intestinal atrophy, zymogen granule loss, and tp53 upregulation — similar to the mutant phenotype. In addition, there was reduction in neutral lipid storage and ribosomal protein amount, similar to the mutant phenotype. Thus, loss of Sbds in zebrafish phenocopies much of the human disease and is associated with growth arrest and tissue atrophy, particularly of the gastrointestinal system, at the larval stage. A variety of stress responses, some associated with Tp53, contribute to pathophysiology of SDS.

18 February 2025 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
UCUsua Oyarbide Cuervas-Mons
Usua Oyarbide Cuervas-Mons
Valentino BezzerriValentino Bezzerri
Valentino Bezzerri
MSMorgan Staton
Morgan Staton
CBChristian Boni
Christian Boni
ASArish Shah
Arish Shah
SCSeth J. Corey
Seth J. Corey
Shwachman-Diamond syndrome (SDS) is characterized by neutropenia, exocrine pancreatic insufficiency, and bony abnormalities with an increased risk of myeloid neoplasia. Almost all cases of SDS result from biallelic mutations in Shwachman-Bodian-Diamond syndrome (SBDS). SBDS interacts with elongation factor–like 1 (EFL1) to displace eukaryotic initiation factor 6 (EIF6) from the 60S ribosomal subunit. Released EIF6 permits the assembly of ribosomal large and small subunits in the cytoplasm. Decreased EIF6 levels due to haploinsufficiency or missense mutations, which lead to decreased protein expression, may provide a somatic genetic rescue and antileukemic effects. We observed accumulation of EIF6 protein in sbds -KO zebrafish models, confirmed this accumulation in patient-derived tissues, and correlated these with changes in ribosomal proteins and tumor protein p53 (TP53) pathways. The mechanism of action for this adaptive response is unknown. To address this, we generated eif6 -KO zebrafish, which do not survive more than 10 days after fertilization. We also created 2 mutants with low Eif6 expression, i.e., 5%–25% of WT levels, that could survive until adulthood. We bred them with sbds -null strains and analyzed their phenotype and biochemical properties. Low Eif6 levels reduced Tp53 pathway activation but did not rescue neutropenia in Sbds-deficient zebrafish. Further studies elucidating the interplay between SBDS, EIF6, and TP53 and cellular stress responses offer promising insights into SDS pathogenesis, somatic genetic rescue, and therapeutic strategies.

30 August 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
ASArish N Shah
Arish N Shah
FLFriederike Leesch
Friederike Leesch
LLLaura Lorenzo-Orts
Laura Lorenzo-Orts
LGLorenz Grundmann
Lorenz Grundmann
MNMaria Novatchkova
Maria Novatchkova
APAndrea Pauli
Andrea Pauli
Protein synthesis during vertebrate embryogenesis is driven by ribosomes of two distinct origins: maternal ribosomes synthesized during oogenesis and stored in the egg, and somatic ribosomes, produced by the developing embryo after zygotic genome activation (ZGA). In zebrafish, these two ribosome types are expressed from different genomic loci and also differ in their ribosomal RNA (rRNA) sequence. To characterize this dual ribosome system further, we examined the expression patterns of maternal and somatic rRNAs during embryogenesis and in adult tissues. We found that maternal rRNAs are not only expressed during oogenesis but are continuously produced in the zebrafish germline. Proteomic analyses of maternal and somatic ribosomes unveiled differences in core ribosomal protein composition. Most nucleotide differences between maternal and somatic rRNAs are located in the flexible, structurally not resolved expansion segments. Our in vivo data demonstrated that both maternal and somatic ribosomes can be translationally active in the embryo. Using transgenically tagged maternal or somatic ribosome subunits, we experimentally confirm the presence of hybrid 80S ribosomes composed of 40S and 60S subunits from both origins and demonstrate the preferential in vivo association of maternal ribosomes with germline-specific transcripts. Our study identifies a distinct type of ribosomes in the zebrafish germline and thus presents a foundation for future explorations into possible regulatory mechanisms and functional roles of heterogeneous ribosomes.

10 October 2023 in Life Science Alliance
Verified
Journal Article
Open access
PDF file
UCUsua Oyarbide Cuervas-Mons
Usua Oyarbide Cuervas-Mons
ASArish N Shah
Arish N Shah
MSMorgan Staton
Morgan Staton
MSMatthew Snyderman
Matthew Snyderman
ASAdya Sapra
Adya Sapra
SCSeth J. Corey
Seth J. Corey
Defects in ribosomal biogenesis profoundly affect organismal development and cellular function, and these ribosomopathies produce a variety of phenotypes. One ribosomopathy, Shwachman–Diamond syndrome (SDS) is characterized by neutropenia, pancreatic exocrine insufficiency, and skeletal anomalies. SDS results from biallelic mutations inSBDS, which encodes a ribosome assembly factor. Some individuals express a missense mutation,SBDSR126T, along with the common K62X mutation. We reported that thesbds-null zebrafish phenocopies much of SDS. We further showed activation of Tp53-dependent pathways before the fish died during the larval stage. Here, we expressedSBDSR126Tas a transgene in thesbds−/−background. We showed that one copy of theSBDSR126Ttransgene permitted the establishment of maternal zygoticsbds-null fish which produced defective embryos withcdkn1aup-regulation, a Tp53 target involved in cell cycle arrest. None survived beyond 3 dpf. However, two copies of the transgene resulted in normal development and lifespan. Surprisingly, neutropenia persisted. The surviving fish displayed suppression of female sex differentiation, a stress response in zebrafish. To evaluate the role of Tp53 in the pathogenesis ofsbds−/−fish phenotype, we bred the fish with a DNA binding deficient allele,tp53M214K. Expression of the loss-of-functiontp53M214Kdid not rescue neutropenia or survival insbds-null zebrafish. Increased expression ofcdkn1awas abrogated in thetp53M214K/M214K;sbds−/−fish. We conclude that the amount of SBDSR126Tprotein is important for development, inactivation of Tp53 fails to rescue neutropenia or survival in thesbds-null background, andcdkn1aup-regulation was dependent on WTtp53. We hypothesize that additional pathways are involved in the pathophysiology of SDS.

4 March 2025 in eLife preprints
Verified
Preprint
Open access
ASArish N Shah
Arish N Shah
FLFriederike Leesch
Friederike Leesch
LLLaura Lorenzo-Orts
Laura Lorenzo-Orts
LGLorenz Grundmann
Lorenz Grundmann
MNMaria Novatchkova
Maria Novatchkova
APAndrea Pauli
Andrea Pauli
Protein synthesis during vertebrate embryogenesis is driven by ribosomes of two distinct origins: maternal ribosomes synthesized during oogenesis and stored in the egg, and somatic ribosomes, produced by the developing embryo after zygotic genome activation (ZGA). In zebrafish, these two ribosome types are expressed from different genomic loci and also differ in their ribosomal RNA (rRNA) sequence. To characterize this dual ribosome system further, we examined the expression patterns of maternal and somatic rRNAs during embryogenesis and in adult tissues. We found that maternal rRNAs are not only expressed during oogenesis but are continuously produced in the zebrafish germline. Proteomic analyses of maternal and somatic ribosomes unveiled differences in core ribosomal protein composition. Most nucleotide differences between maternal and somatic rRNAs are located in the flexible, structurally not resolved expansion segments. Our in vivo data demonstrated that both maternal and somatic ribosomes can be translationally active in the embryo. Using transgenically tagged maternal or somatic ribosome subunits, we experimentally confirm the presence of hybrid 80S ribosomes composed of 40S and 60S subunits from both origins and demonstrate the preferential in vivo association of maternal ribosomes with germline-specific transcripts. Our study identifies a distinct type of ribosomes in the zebrafish germline and thus presents a foundation for future explorations into possible regulatory mechanisms and functional roles of heterogeneous ribosomes.